Amide Local Anesthetic [EPC]

Amide Local Anesthetic [EPC] was reported 87229 times

These side effects are most commonly reported by patients taking drugs of the Amide Local Anesthetic [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 6783
1 OFF LABEL USE 5868
2 PAIN 5681
3 NAUSEA 5140
4 FATIGUE 4883
5 HEADACHE 4515
6 DYSPNOEA 3684
7 PRODUCT ADHESION ISSUE 3517
8 PRODUCT QUALITY ISSUE 3403
9 DIARRHOEA 3286
10 PNEUMONIA 3148
11 VOMITING 3110
12 DIZZINESS 2981
13 SINUSITIS 2821
14 FALL 2779
15 HYPOTENSION 2640
16 PRODUCT DOSE OMISSION ISSUE 2525
17 DEATH 2513
18 PYREXIA 2478
19 ARTHRALGIA 2251
20 MALAISE 2244
21 BACK PAIN 2235
22 URINARY TRACT INFECTION 2207
23 ANXIETY 2155
24 RASH 2134
25 ASTHENIA 2119
26 COUGH 2071
27 PAIN IN EXTREMITY 1988
28 COVID-19 1949
29 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1938
30 WEIGHT DECREASED 1878
31 PRURITUS 1821
32 TOXICITY TO VARIOUS AGENTS 1700
33 DRUG HYPERSENSITIVITY 1686
34 PRODUCT USE IN UNAPPROVED INDICATION 1638
35 NASOPHARYNGITIS 1632
36 HYPERTENSION 1601
37 INFUSION SITE PAIN 1579
38 RENAL FAILURE 1576
39 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1573
40 CONSTIPATION 1557
41 CARDIAC ARREST 1455
42 CONDITION AGGRAVATED 1446
43 SOMNOLENCE 1441
44 INSOMNIA 1414
45 HYPOAESTHESIA 1382
46 ABDOMINAL PAIN 1342
47 DECREASED APPETITE 1342
48 ACUTE KIDNEY INJURY 1335
49 INFECTION 1313
50 BRONCHITIS 1292
51 DEPRESSION 1272
52 CHEST PAIN 1263
53 ANAEMIA 1252
54 NO ADVERSE EVENT 1240
55 ILLNESS 1219
56 CHRONIC KIDNEY DISEASE 1206
57 PRODUCT USE ISSUE 1205
58 ERYTHEMA 1203
59 FEELING ABNORMAL 1187
60 DRUG INTERACTION 1183
61 WEIGHT INCREASED 1171
62 MUSCLE SPASMS 1167
63 BLOOD PRESSURE INCREASED 1135
64 CONFUSIONAL STATE 1127
65 LOSS OF CONSCIOUSNESS 1117
66 INFLUENZA 1112
67 UPPER RESPIRATORY TRACT INFECTION 1111
68 OVERDOSE 1110
69 GAIT DISTURBANCE 1100
70 ANAPHYLACTIC REACTION 1080
71 HYPERSENSITIVITY 1050
72 SEPSIS 1033
73 PERIPHERAL SWELLING 1028
74 TREMOR 1028
75 INFUSION SITE ERYTHEMA 1020
76 SEIZURE 1019
77 CHILLS 1010
78 URTICARIA 997
79 PARAESTHESIA 987
80 BRADYCARDIA 964
81 INJECTION SITE PAIN 963
82 TACHYCARDIA 960
83 MUSCULAR WEAKNESS 948
84 DEHYDRATION 936
85 CONTUSION 932
86 MIGRAINE 928
87 OEDEMA PERIPHERAL 922
88 INFUSION RELATED REACTION 892
89 INFUSION SITE SWELLING 882
90 ABDOMINAL PAIN UPPER 881
91 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 872
92 HYPERHIDROSIS 855
93 MYALGIA 843
94 INJURY 813
95 SWELLING 811
96 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 793
97 ABDOMINAL DISCOMFORT 786
98 ATRIAL FIBRILLATION 784
99 STRESS 780
100 ASTHMA 777
101 MATERNAL EXPOSURE DURING PREGNANCY 775
102 EMOTIONAL DISTRESS 758
103 EAR INFECTION 747
104 INSURANCE ISSUE 735
105 ABDOMINAL DISTENSION 728
106 NEUROPATHY PERIPHERAL 727
107 ANAPHYLACTIC SHOCK 722
108 HEART RATE INCREASED 715
109 UNEVALUABLE EVENT 715
110 OROPHARYNGEAL PAIN 712
111 VISION BLURRED 708
112 CELLULITIS 700
113 RESPIRATORY TRACT INFECTION 699
114 CEREBROVASCULAR ACCIDENT 691
115 CHEST DISCOMFORT 689
116 RESPIRATORY FAILURE 685
117 SYNCOPE 680
118 MEMORY IMPAIRMENT 679
119 PALPITATIONS 679
120 GASTROOESOPHAGEAL REFLUX DISEASE 673
121 OXYGEN SATURATION DECREASED 671
122 ALOPECIA 669
123 INCORRECT DOSE ADMINISTERED 664
124 HYPOXIA 663
125 FEBRILE NEUTROPENIA 658
126 EXPOSURE DURING PREGNANCY 653
127 HOSPITALISATION 653
128 BLOOD PRESSURE DECREASED 650
129 NECK PAIN 630
130 SEASONAL ALLERGY 621
131 DYSPHAGIA 617
132 PULMONARY EMBOLISM 593
133 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 591
134 GASTROINTESTINAL DISORDER 588
135 JOINT SWELLING 588
136 HERPES ZOSTER 586
137 PLATELET COUNT DECREASED 579
138 INFUSION SITE HAEMORRHAGE 578
139 INTENTIONAL PRODUCT USE ISSUE 570
140 BURNING SENSATION 568
141 PLEURAL EFFUSION 568
142 ARTHRITIS 557
143 PRODUCTIVE COUGH 544
144 HAEMOGLOBIN DECREASED 543
145 OEDEMA 541
146 BALANCE DISORDER 532
147 DRUG INTOLERANCE 532
148 DRY MOUTH 531
149 INFLUENZA LIKE ILLNESS 528
150 WHITE BLOOD CELL COUNT DECREASED 527
151 THERAPY NON-RESPONDER 526
152 UNRESPONSIVE TO STIMULI 519
153 VISUAL IMPAIRMENT 518
154 MENTAL STATUS CHANGES 515
155 THROMBOSIS 515
156 VIRAL INFECTION 511
157 DERMATITIS CONTACT 506
158 FLUSHING 506
159 RENAL INJURY 506
160 STAPHYLOCOCCAL INFECTION 502
161 EPISTAXIS 501
162 MUSCULOSKELETAL STIFFNESS 498
163 MYOCARDIAL INFARCTION 497
164 END STAGE RENAL DISEASE 494
165 NEUTROPENIA 492
166 AGITATION 488
167 THROMBOCYTOPENIA 487
168 HAEMORRHAGE 486
169 DYSPEPSIA 485
170 CATARACT 481
171 GENERAL PHYSICAL HEALTH DETERIORATION 479
172 RENAL IMPAIRMENT 479
173 INFUSION SITE PRURITUS 472
174 LETHARGY 467
175 CARDIAC DISORDER 463
176 DRUG WITHDRAWAL SYNDROME 462
177 ANHEDONIA 456
178 BLOOD GLUCOSE INCREASED 454
179 INFUSION SITE DISCHARGE 453
180 DISCOMFORT 452
181 VENTRICULAR TACHYCARDIA 447
182 NASAL CONGESTION 442
183 NEURALGIA 442
184 HYPOKALAEMIA 440
185 RHEUMATOID ARTHRITIS 440
186 MULTIPLE ALLERGIES 439
187 FOETAL EXPOSURE DURING PREGNANCY 435
188 BLISTER 434
189 CYSTITIS 430
190 WHEEZING 430
191 SLEEP DISORDER 428
192 HYPONATRAEMIA 426
193 INTENTIONAL PRODUCT MISUSE 424
194 GENERALISED TONIC-CLONIC SEIZURE 422
195 OSTEOARTHRITIS 422
196 CARDIAC FAILURE CONGESTIVE 418
197 STOMATITIS 418
198 DISEASE PROGRESSION 415
199 PULMONARY OEDEMA 413
200 FEAR 403
201 DIABETES MELLITUS 402
202 RHINORRHOEA 402
203 DEVICE ISSUE 401
204 DYSARTHRIA 401
205 HALLUCINATION 401
206 MUSCULOSKELETAL PAIN 397
207 VERTIGO 390
208 ADVERSE DRUG REACTION 388
209 CARDIO-RESPIRATORY ARREST 387
210 DEEP VEIN THROMBOSIS 386
211 NEPHROLITHIASIS 386
212 FLUID RETENTION 385
213 URINARY RETENTION 384
214 MATERNAL EXPOSURE DURING DELIVERY 381
215 SWELLING FACE 379
216 DYSPHONIA 378
217 INJECTION SITE ERYTHEMA 377
218 DYSPNOEA EXERTIONAL 375
219 GASTROENTERITIS VIRAL 369
220 SURGERY 367
221 MALIGNANT NEOPLASM PROGRESSION 366
222 DRUG ABUSE 365
223 OSTEOPOROSIS 364
224 AMNESIA 363
225 MOBILITY DECREASED 362
226 PREMATURE BABY 362
227 SUICIDAL IDEATION 358
228 GASTROINTESTINAL HAEMORRHAGE 354
229 TREATMENT FAILURE 354
230 DEPRESSED LEVEL OF CONSCIOUSNESS 353
231 INFUSION SITE EXTRAVASATION 351
232 VENTRICULAR FIBRILLATION 351
233 FUNGAL INFECTION 348
234 POST PROCEDURAL COMPLICATION 345
235 LOWER RESPIRATORY TRACT INFECTION 344
236 ROAD TRAFFIC ACCIDENT 343
237 FIBROMYALGIA 341
238 SINUS DISORDER 340
239 EYE PAIN 338
240 PROCEDURAL PAIN 338
241 BONE PAIN 336
242 MEDICATION ERROR 336
243 CARDIAC FAILURE 333
244 DRY SKIN 333
245 COMA 332
246 SPEECH DISORDER 332
247 BLOOD CREATININE INCREASED 331
248 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 331
249 DEVICE INFUSION ISSUE 330
250 CONVULSION 329
251 LIMB INJURY 327
252 LOCALISED INFECTION 326
253 DELIRIUM 324
254 METHAEMOGLOBINAEMIA 323
255 RESPIRATORY ARREST 323
256 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 322
257 FEELING HOT 320
258 TINNITUS 319
259 PAIN IN JAW 316
260 DEVICE DISLOCATION 314
261 ALANINE AMINOTRANSFERASE INCREASED 313
262 INFUSION SITE BRUISING 313
263 ANAESTHETIC COMPLICATION 312
264 ACCIDENTAL OVERDOSE 311
265 ARTHROPATHY 308
266 BACTERIAL INFECTION 308
267 BLOOD CHOLESTEROL INCREASED 308
268 LUNG DISORDER 305
269 CARDIOGENIC SHOCK 304
270 KIDNEY INFECTION 304
271 DRUG DOSE OMISSION 303
272 DYSGEUSIA 302
273 RENAL FAILURE ACUTE 302
274 ASPARTATE AMINOTRANSFERASE INCREASED 301
275 HEART RATE DECREASED 297
276 HOT FLUSH 297
277 SINUS TACHYCARDIA 296
278 SKIN DISCOLOURATION 296
279 DIPLOPIA 295
280 RESPIRATORY DEPRESSION 295
281 RIB FRACTURE 290
282 NEPHROGENIC ANAEMIA 289
283 DRUG DEPENDENCE 288
284 SEPTIC SHOCK 288
285 APPLICATION SITE PAIN 287
286 ARRHYTHMIA 284
287 ACUTE RESPIRATORY FAILURE 283
288 MULTIPLE ORGAN DYSFUNCTION SYNDROME 282
289 RASH PRURITIC 282
290 THERAPEUTIC RESPONSE DECREASED 282
291 RESPIRATORY DISTRESS 281
292 URINARY INCONTINENCE 281
293 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 280
294 NEUROTOXICITY 279
295 EXPIRED PRODUCT ADMINISTERED 277
296 SEDATION 277
297 METABOLIC ACIDOSIS 276
298 INTERVERTEBRAL DISC PROTRUSION 274
299 DISORIENTATION 272
300 SKIN EXFOLIATION 272
301 DEVICE MALFUNCTION 269
302 DYSURIA 269
303 NERVOUSNESS 269
304 PANCYTOPENIA 268
305 INJECTION SITE SWELLING 267
306 POOR VENOUS ACCESS 267
307 DISTURBANCE IN ATTENTION 264
308 DYSKINESIA 264
309 INFLAMMATION 264
310 IMPAIRED HEALING 263
311 ACCIDENTAL EXPOSURE TO PRODUCT 262
312 HEAD INJURY 261
313 STATUS EPILEPTICUS 260
314 ELECTROCARDIOGRAM QT PROLONGED 258
315 LYMPHADENOPATHY 258
316 MULTI-ORGAN FAILURE 258
317 ANGIOEDEMA 257
318 CIRCULATORY COLLAPSE 257
319 COGNITIVE DISORDER 257
320 THERAPY INTERRUPTED 256
321 BLOOD POTASSIUM DECREASED 253
322 APPLICATION SITE ERYTHEMA 251
323 PALLOR 251
324 WHITE BLOOD CELL COUNT INCREASED 251
325 SLEEP APNOEA SYNDROME 250
326 INFUSION SITE REACTION 249
327 RESTLESSNESS 249
328 INCORRECT DRUG ADMINISTRATION RATE 247
329 RESPIRATORY DISORDER 246
330 ASCITES 245
331 DRUG EFFECT DECREASED 242
332 TOOTH INFECTION 242
333 DEVICE FAILURE 241
334 DIVERTICULITIS 238
335 HAEMORRHOIDS 238
336 RENAL DISORDER 238
337 MENTAL DISORDER 237
338 PNEUMONIA ASPIRATION 237
339 NEUTROPHIL COUNT DECREASED 236
340 POOR QUALITY SLEEP 236
341 ADVERSE EVENT 235
342 FLATULENCE 234
343 HEPATIC ENZYME INCREASED 234
344 HAEMATOMA 233
345 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 233
346 ENCEPHALOPATHY 232
347 PRODUCT DISTRIBUTION ISSUE 232
348 MYOCLONUS 231
349 PSORIASIS 231
350 HYPOAESTHESIA ORAL 230
351 CANDIDA INFECTION 229
352 THROAT IRRITATION 229
353 BLINDNESS 228
354 RECTAL HAEMORRHAGE 227
355 APHASIA 226
356 HYPERKALAEMIA 226
357 RASH ERYTHEMATOUS 225
358 SKIN DISORDER 224
359 THERAPEUTIC RESPONSE UNEXPECTED 224
360 NEOPLASM MALIGNANT 223
361 WITHDRAWAL SYNDROME 223
362 LIMB DISCOMFORT 222
363 DEVICE OCCLUSION 221
364 DRY EYE 221
365 JOINT INJURY 221
366 PULMONARY HYPERTENSION 220
367 SCAR 220
368 FOOT FRACTURE 219
369 HYPERLIPIDAEMIA 219
370 SKIN INFECTION 219
371 TRANSIENT ISCHAEMIC ATTACK 218
372 PHARYNGITIS STREPTOCOCCAL 217
373 SKIN ULCER 217
374 APNOEA 216
375 COLITIS 216
376 PRODUCT AVAILABILITY ISSUE 216
377 BODY TEMPERATURE INCREASED 215
378 BRONCHOSPASM 215
379 INJECTION SITE BRUISING 215
380 DEVICE LEAKAGE 212
381 LIP SWELLING 212
382 HAEMOPTYSIS 209
383 ATELECTASIS 208
384 SWOLLEN TONGUE 208
385 GAIT INABILITY 206
386 INTERVERTEBRAL DISC DEGENERATION 206
387 NERVOUS SYSTEM DISORDER 206
388 HYPOTHYROIDISM 205
389 NIGHT SWEATS 205
390 OSTEOMYELITIS 205
391 WOUND 205
392 SCIATICA 204
393 THERAPEUTIC PRODUCT EFFECT DECREASED 204
394 IRRITABLE BOWEL SYNDROME 203
395 TOXIC ANTERIOR SEGMENT SYNDROME 203
396 INFUSION SITE INFECTION 201
397 ECONOMIC PROBLEM 200
398 INFUSION SITE MASS 200
399 SEROTONIN SYNDROME 200
400 MYDRIASIS 199
401 POLLAKIURIA 199
402 THERAPY PARTIAL RESPONDER 198
403 HIP FRACTURE 197
404 CLOSTRIDIUM DIFFICILE INFECTION 196
405 PREMATURE DELIVERY 196
406 RED BLOOD CELL COUNT DECREASED 196
407 INTESTINAL OBSTRUCTION 195
408 IRRITABILITY 195
409 INJECTION SITE REACTION 194
410 ORAL PAIN 194
411 TENDERNESS 193
412 SKIN LACERATION 192
413 SHOCK 191
414 C-REACTIVE PROTEIN INCREASED 190
415 DEPRESSED MOOD 190
416 HAEMATOCHEZIA 190
417 INJECTION SITE PRURITUS 190
418 PNEUMOTHORAX 190
419 RESPIRATORY TRACT CONGESTION 190
420 MUSCULOSKELETAL CHEST PAIN 189
421 HAEMATOCRIT DECREASED 188
422 INFUSION SITE IRRITATION 188
423 NERVE INJURY 188
424 SPINAL OSTEOARTHRITIS 188
425 PARALYSIS 187
426 CHOLELITHIASIS 186
427 INTENTIONAL OVERDOSE 185
428 PLASMA CELL MYELOMA 185
429 TREATMENT NONCOMPLIANCE 185
430 BLOOD PRESSURE ABNORMAL 184
431 EYE INFECTION 184
432 MUSCLE TWITCHING 184
433 VISUAL ACUITY REDUCED 184
434 EAR PAIN 183
435 LYMPHOCYTE COUNT DECREASED 183
436 CYANOSIS 182
437 HYPERSOMNIA 182
438 ILL-DEFINED DISORDER 182
439 HAEMATURIA 181
440 HYPOACUSIS 181
441 APPLICATION SITE RASH 180
442 EYE IRRITATION 179
443 HYPERAESTHESIA 179
444 TOOTH DISORDER 179
445 VENTRICULAR EXTRASYSTOLES 179
446 LIVE BIRTH 178
447 SENSORY LOSS 178
448 CROHN^S DISEASE 177
449 GASTRITIS 176
450 GOUT 176
451 NEEDLE ISSUE 176
452 COMPLETED SUICIDE 175
453 INCORRECT ROUTE OF DRUG ADMINISTRATION 175
454 MUSCULOSKELETAL DISCOMFORT 175
455 OSTEOPENIA 175
456 STRESS CARDIOMYOPATHY 175
457 PRODUCT DOSE OMISSION 174
458 SPINAL FRACTURE 174
459 ACUTE MYOCARDIAL INFARCTION 173
460 FEELING COLD 172
461 DYSSTASIA 171
462 HYPOGLYCAEMIA 171
463 IMPAIRED GASTRIC EMPTYING 171
464 PANIC ATTACK 171
465 PANCREATITIS 170
466 PHARYNGITIS 170
467 PRESYNCOPE 170
468 PRODUCT ADMINISTRATION INTERRUPTED 170
469 ROTATOR CUFF SYNDROME 170
470 HAEMODYNAMIC INSTABILITY 169
471 BONE DENSITY DECREASED 168
472 PRODUCT ADMINISTRATION ERROR 168
473 BRAIN OEDEMA 167
474 INFUSION SITE INDURATION 167
475 INFUSION SITE RASH 166
476 CARPAL TUNNEL SYNDROME 165
477 LEUKOPENIA 165
478 IMPAIRED QUALITY OF LIFE 164
479 JOINT STIFFNESS 164
480 MUSCLE SPASTICITY 164
481 ORAL HERPES 164
482 WEIGHT FLUCTUATION 164
483 RASH MACULAR 163
484 CONJUNCTIVITIS 162
485 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 162
486 INFUSION SITE WARMTH 162
487 ECZEMA 161
488 MUCOSAL INFLAMMATION 161
489 OCULAR HYPERAEMIA 161
490 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 161
491 DISABILITY 160
492 HORNER^S SYNDROME 160
493 HYPERPARATHYROIDISM SECONDARY 160
494 HYPOPHOSPHATAEMIA 160
495 LIVER DISORDER 160
496 PERICARDIAL EFFUSION 160
497 SINUS CONGESTION 159
498 SYSTEMIC LUPUS ERYTHEMATOSUS 159
499 APPENDICITIS 158
500 PARAESTHESIA ORAL 158
501 APPLICATION SITE PRURITUS 157
502 JOINT RANGE OF MOTION DECREASED 157
503 MULTIPLE SCLEROSIS RELAPSE 157
504 MYASTHENIA GRAVIS 157
505 RHABDOMYOLYSIS 157
506 DRUG LEVEL INCREASED 156
507 HIATUS HERNIA 156
508 LEUKOCYTOSIS 156
509 SINUS BRADYCARDIA 156
510 BLOOD GLUCOSE DECREASED 155
511 EXTRA DOSE ADMINISTERED 155
512 BRAIN FOG 154
513 CYTOKINE RELEASE SYNDROME 154
514 PRODUCT DOSE OMISSION IN ERROR 154
515 PRODUCT SUBSTITUTION ISSUE 154
516 PULSELESS ELECTRICAL ACTIVITY 154
517 TOOTH ABSCESS 154
518 BODY HEIGHT DECREASED 153
519 CORONARY ARTERY DISEASE 152
520 GASTROINTESTINAL INFECTION 152
521 TACHYPNOEA 152
522 TOOTHACHE 152
523 MOUTH ULCERATION 150
524 SKIN BURNING SENSATION 150
525 WRONG TECHNIQUE IN DRUG USAGE PROCESS 150
526 CARDIOMEGALY 149
527 HYPERGLYCAEMIA 149
528 PULMONARY MASS 149
529 THROAT TIGHTNESS 149
530 ULCER 149
531 COMPLICATION ASSOCIATED WITH DEVICE 148
532 CRYING 148
533 DEVICE RELATED INFECTION 148
534 HALLUCINATION, VISUAL 148
535 INJECTION SITE HAEMORRHAGE 148
536 RESTLESS LEGS SYNDROME 148
537 SKIN IRRITATION 148
538 SKIN LESION 148
539 ANKLE FRACTURE 147
540 COLD SWEAT 147
541 DRUG TOXICITY 147
542 EYE SWELLING 147
543 INCORRECT PRODUCT ADMINISTRATION DURATION 147
544 BLOOD SODIUM DECREASED 146
545 UPPER LIMB FRACTURE 146
546 BACK DISORDER 145
547 BURSITIS 145
548 INFUSION SITE NODULE 145
549 TUBULOINTERSTITIAL NEPHRITIS 145
550 BLOOD UREA INCREASED 144
551 BONE DISORDER 144
552 LOWER LIMB FRACTURE 144
553 MASS 144
554 MOVEMENT DISORDER 143
555 ORAL CANDIDIASIS 143
556 DEVICE DIFFICULT TO USE 142
557 HEMIPARESIS 142
558 KOUNIS SYNDROME 142
559 PULSE ABSENT 142
560 EATING DISORDER 141
561 SPINAL OPERATION 141
562 BLOOD PRESSURE FLUCTUATION 140
563 INADEQUATE ANALGESIA 140
564 SMALL INTESTINAL OBSTRUCTION 140
565 UNDERDOSE 140
566 BLOOD BILIRUBIN INCREASED 139
567 CHROMATURIA 139
568 INTENTIONAL DOSE OMISSION 139
569 MULTIPLE SCLEROSIS 139
570 DECUBITUS ULCER 138
571 JOINT DISLOCATION 138
572 LACRIMATION INCREASED 138
573 LIVER FUNCTION TEST INCREASED 138
574 TYPE 2 DIABETES MELLITUS 138
575 AGGRESSION 137
576 HEART RATE IRREGULAR 137
577 HYPOPHAGIA 137
578 PROCEDURAL COMPLICATION 137
579 BREAST CANCER 135
580 DEAFNESS 135
581 NO THERAPEUTIC RESPONSE 135
582 PRESCRIBED OVERDOSE 135
583 APPLICATION SITE IRRITATION 134
584 MUSCLE TIGHTNESS 134
585 OSTEONECROSIS 134
586 RESPIRATORY SYNCYTIAL VIRUS INFECTION 134
587 RETCHING 134
588 ANGINA PECTORIS 133
589 CLOSTRIDIUM DIFFICILE COLITIS 133
590 ALTERED STATE OF CONSCIOUSNESS 132
591 COVID-19 PNEUMONIA 132
592 EXOSTOSIS 132
593 EYE DISORDER 132
594 PNEUMONITIS 131
595 IMPAIRED WORK ABILITY 130
596 PSEUDOMONAS INFECTION 130
597 BLOOD ALKALINE PHOSPHATASE INCREASED 129
598 PHOTOPHOBIA 129
599 PSORIATIC ARTHROPATHY 129
600 PULMONARY CONGESTION 129
601 SNEEZING 129
602 SPINAL PAIN 129
603 SUPRAVENTRICULAR TACHYCARDIA 129
604 MENTAL IMPAIRMENT 127
605 THERAPEUTIC RESPONSE SHORTENED 127
606 ABSCESS 126
607 GRAND MAL CONVULSION 126
608 APHONIA 125
609 INCONTINENCE 125
610 SUICIDE ATTEMPT 125
611 HERNIA 124
612 OSTEONECROSIS OF JAW 124
613 THERAPY CESSATION 124
614 HYPOCALCAEMIA 123
615 INFUSION SITE DISCOMFORT 123
616 INJECTION SITE MASS 123
617 TASTE DISORDER 123
618 ACUTE RESPIRATORY DISTRESS SYNDROME 122
619 DYSTONIA 122
620 MOTOR DYSFUNCTION 122
621 STREPTOCOCCAL INFECTION 122
622 WOUND INFECTION 122
623 ABNORMAL BEHAVIOUR 121
624 FEMUR FRACTURE 121
625 OBSTRUCTIVE AIRWAYS DISORDER 121
626 RASH MACULO-PAPULAR 121
627 BACK INJURY 120
628 HYPERCHOLESTEROLAEMIA 120
629 INCORRECT DRUG ADMINISTRATION DURATION 120
630 OBSTRUCTION 120
631 APPLICATION SITE BURN 119
632 BLOOD URINE PRESENT 119
633 DEVICE USE ERROR 119
634 HEREDITARY ANGIOEDEMA 119
635 KNEE ARTHROPLASTY 119
636 MALNUTRITION 119
637 RENAL TUBULAR NECROSIS 119
638 ACCIDENT 118
639 DRUG EXPOSURE DURING PREGNANCY 118
640 HYPOMAGNESAEMIA 118
641 INABILITY TO AFFORD MEDICATION 118
642 LIGAMENT SPRAIN 118
643 POST PROCEDURAL INFECTION 118
644 ASPIRATION 117
645 HEPATIC STEATOSIS 117
646 PRE-EXISTING CONDITION IMPROVED 117
647 DIZZINESS POSTURAL 116
648 DRUG EFFECT INCOMPLETE 116
649 GLAUCOMA 116
650 INTERNATIONAL NORMALISED RATIO INCREASED 116
651 LARYNGITIS 116
652 LOW BIRTH WEIGHT BABY 116
653 NEOPLASM PROGRESSION 116
654 NIGHTMARE 116
655 ACTIVITIES OF DAILY LIVING IMPAIRED 115
656 AUTOIMMUNE DISORDER 115
657 CHRONIC SINUSITIS 115
658 EYELID PTOSIS 115
659 FOETAL EXPOSURE DURING DELIVERY 115
660 FULL BLOOD COUNT DECREASED 115
661 PURULENT DISCHARGE 115
662 REBOUND ACID HYPERSECRETION 115
663 CEREBRAL HAEMORRHAGE 114
664 DEVICE MAINTENANCE ISSUE 114
665 GASTRIC DISORDER 114
666 MITRAL VALVE INCOMPETENCE 114
667 PARAPLEGIA 114
668 PULMONARY FIBROSIS 114
669 COAGULOPATHY 113
670 DEMENTIA 113
671 DRUG ADMINISTRATION ERROR 113
672 LUNG INFECTION 113
673 VITAMIN D DEFICIENCY 113
674 ANAL INCONTINENCE 112
675 BACTERAEMIA 112
676 HYPERPHOSPHATAEMIA 112
677 IRON DEFICIENCY 112
678 PROCTALGIA 112
679 PULMONARY ARTERIAL HYPERTENSION 112
680 RASH PAPULAR 112
681 BRONCHIECTASIS 111
682 CARDIOTOXICITY 111
683 EMOTIONAL DISORDER 111
684 GALLBLADDER DISORDER 111
685 HIP ARTHROPLASTY 111
686 MIOSIS 111
687 NORMAL NEWBORN 111
688 THERMAL BURN 111
689 ARTHRITIS INFECTIVE 110
690 BLOOD PRESSURE SYSTOLIC INCREASED 110
691 FLANK PAIN 110
692 FOOD ALLERGY 110
693 HYPOTHERMIA 110
694 ATAXIA 109
695 IMPLANT SITE PAIN 109
696 MICTURITION URGENCY 109
697 OBESITY 109
698 VAGINAL HAEMORRHAGE 109
699 BLOOD URIC ACID INCREASED 108
700 EPILEPSY 108
701 NERVE COMPRESSION 108
702 CARDIOMYOPATHY 107
703 FEEDING DISORDER 107
704 ILEUS 107
705 SKIN CANCER 107
706 BLOOD PHOSPHORUS INCREASED 106
707 BRAIN INJURY 106
708 DEVICE BREAKAGE 106
709 PRODUCT STORAGE ERROR 106
710 VASCULAR DEVICE INFECTION 106
711 ACNE 105
712 DERMATITIS 105
713 EJECTION FRACTION DECREASED 105
714 HEPATIC FAILURE 105
715 SKIN ABRASION 105
716 SPINAL COMPRESSION FRACTURE 105
717 TOXIC EPIDERMAL NECROLYSIS 105
718 TROPONIN INCREASED 105
719 WRONG PRODUCT ADMINISTERED 105
720 ABASIA 104
721 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 104
722 INTERSTITIAL LUNG DISEASE 104
723 TENDONITIS 104
724 TORSADE DE POINTES 104
725 WRIST FRACTURE 104
726 IRON DEFICIENCY ANAEMIA 103
727 POSTOPERATIVE WOUND INFECTION 103
728 BLOOD CALCIUM DECREASED 102
729 DENTAL CARIES 102
730 FACIAL PAIN 102
731 GASTRIC ULCER 102
732 HAEMATEMESIS 102
733 PRODUCT PRESCRIBING ISSUE 102
734 PSYCHOTIC DISORDER 102
735 TOOTH LOSS 102
736 GLUCOSE TOLERANCE IMPAIRED 101
737 INSPIRATORY CAPACITY DECREASED 101
738 APPENDICOLITH 100
739 ARTHROPOD BITE 100
740 CONCUSSION 100
741 FACIAL PARALYSIS 100
742 LABORATORY TEST ABNORMAL 100
743 NODULE 100
744 BLOOD POTASSIUM INCREASED 99
745 HYPERVOLAEMIA 99
746 INFUSION SITE DISCOLOURATION 99
747 MENINGITIS ASEPTIC 99
748 RESPIRATORY ACIDOSIS 99
749 BASAL CELL CARCINOMA 98
750 CAUDA EQUINA SYNDROME 98
751 MOOD ALTERED 98
752 MUSCLE STRAIN 98
753 RENAL CYST 98
754 SPINAL DISORDER 98
755 THYROID DISORDER 98
756 CONTRAINDICATED PRODUCT ADMINISTERED 97
757 HEPATIC FUNCTION ABNORMAL 97
758 MUSCLE RIGIDITY 97
759 NYSTAGMUS 97
760 SECRETION DISCHARGE 97
761 ESCHERICHIA INFECTION 96
762 MENINGITIS 96
763 PROCEDURAL HYPOTENSION 96
764 SENSORY DISTURBANCE 96
765 ARTHRITIS BACTERIAL 95
766 EYE PRURITUS 95
767 BLOOD CREATINE PHOSPHOKINASE INCREASED 94
768 DEVICE POWER SOURCE ISSUE 94
769 HEAD DISCOMFORT 94
770 HYPOTONIA 94
771 MUSCULOSKELETAL DISORDER 94
772 ORTHOSTATIC HYPOTENSION 94
773 PREGNANCY 94
774 BLOOD IRON DECREASED 93
775 DISSEMINATED INTRAVASCULAR COAGULATION 93
776 METASTASES TO BONE 93
777 BLADDER DISORDER 92
778 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 92
779 HOSPICE CARE 92
780 PNEUMONIA BACTERIAL 92
781 POST PROCEDURAL HAEMORRHAGE 92
782 QUALITY OF LIFE DECREASED 92
783 STEVENS-JOHNSON SYNDROME 92
784 AGEUSIA 91
785 APPLICATION SITE VESICLES 91
786 TOOTH FRACTURE 91
787 TRICUSPID VALVE INCOMPETENCE 91
788 CAESAREAN SECTION 90
789 CYST 90
790 DRUG EFFECT LESS THAN EXPECTED 90
791 ELECTROLYTE IMBALANCE 90
792 LIVER FUNCTION TEST ABNORMAL 90
793 LUNG INFILTRATION 90
794 OESOPHAGITIS 90
795 SPINAL CORD COMPRESSION 90
796 UPPER-AIRWAY COUGH SYNDROME 90
797 VITREOUS FLOATERS 90
798 BLOOD TEST ABNORMAL 89
799 INFUSION SITE URTICARIA 89
800 LIVER INJURY 89
801 CATHETER SITE PAIN 88
802 DERMATITIS ALLERGIC 88
803 ENDOPHTHALMITIS 88
804 GLOSSODYNIA 88
805 HYPOKINESIA 88
806 LEFT VENTRICULAR DYSFUNCTION 88
807 PERICARDITIS 88
808 PERONEAL NERVE PALSY 88
809 DEVICE ALARM ISSUE 87
810 EMPHYSEMA 87
811 GENERALISED OEDEMA 87
812 HAND FRACTURE 87
813 PELVIC PAIN 87
814 PRODUCT PREPARATION ERROR 87
815 SCRATCH 87
816 HYPERCAPNIA 86
817 NEUTROPHIL COUNT INCREASED 86
818 PHARYNGEAL SWELLING 86
819 SUBDURAL HAEMATOMA 86
820 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 85
821 DISEASE RECURRENCE 85
822 ECCHYMOSIS 85
823 LACTIC ACIDOSIS 85
824 PHOTOSENSITIVITY REACTION 85
825 PURPURA 85
826 RHINOVIRUS INFECTION 85
827 SCOLIOSIS 85
828 TRANSAMINASES INCREASED 85
829 BEDRIDDEN 84
830 DRUG-INDUCED LIVER INJURY 84
831 HEPATIC CIRRHOSIS 84
832 OTITIS MEDIA 84
833 SPUTUM DISCOLOURED 84
834 FOOT DEFORMITY 83
835 HYPERTHERMIA MALIGNANT 83
836 HYPOALBUMINAEMIA 83
837 SENSITIVE SKIN 83
838 ABDOMINAL PAIN LOWER 82
839 ADRENAL INSUFFICIENCY 82
840 APPLICATION SITE DISCOMFORT 82
841 BUNDLE BRANCH BLOCK LEFT 82
842 DIVERTICULUM 82
843 FAECES DISCOLOURED 82
844 GROIN PAIN 82
845 JOINT EFFUSION 82
846 LUNG NEOPLASM MALIGNANT 82
847 MUSCLE ATROPHY 82
848 MYOCARDIAL ISCHAEMIA 82
849 NEPHROPATHY 82
850 PARANOIA 82
851 PSYCHOMOTOR HYPERACTIVITY 82
852 BLOOD ALBUMIN DECREASED 81
853 BLOOD TRIGLYCERIDES INCREASED 81
854 INTRAOCULAR PRESSURE INCREASED 81
855 LAGOPHTHALMOS 81
856 MOOD SWINGS 81
857 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 81
858 RALES 81
859 UROSEPSIS 81
860 ABNORMAL DREAMS 80
861 ATRIOVENTRICULAR BLOCK COMPLETE 80
862 COLITIS ULCERATIVE 80
863 FACE OEDEMA 80
864 PRODUCT PHYSICAL ISSUE 80
865 PULMONARY THROMBOSIS 80
866 SKIN NECROSIS 80
867 LOCAL SWELLING 79
868 SPINAL COLUMN STENOSIS 79
869 SYNOVITIS 79
870 TRANSFUSION 79
871 ANAESTHETIC COMPLICATION NEUROLOGICAL 78
872 BLOOD CALCIUM INCREASED 78
873 FOOD POISONING 78
874 HYPOVOLAEMIA 78
875 IMMUNODEFICIENCY 78
876 ANGER 77
877 CORNEAL OEDEMA 77
878 FEELING JITTERY 77
879 FREQUENT BOWEL MOVEMENTS 77
880 PARKINSON^S DISEASE 77
881 PERIPHERAL COLDNESS 77
882 PRODUCT USE COMPLAINT 77
883 UPPER GASTROINTESTINAL HAEMORRHAGE 77
884 BLOOD MAGNESIUM DECREASED 76
885 EXTRAPYRAMIDAL DISORDER 76
886 LUMBAR SPINAL STENOSIS 76
887 LYMPHOEDEMA 76
888 OCULAR DISCOMFORT 76
889 PAIN OF SKIN 76
890 PHARMACEUTICAL PRODUCT COMPLAINT 76
891 RHINITIS 76
892 INFUSION SITE INFLAMMATION 75
893 MIDDLE INSOMNIA 75
894 PERIPHERAL VASCULAR DISORDER 75
895 RESPIRATORY RATE INCREASED 75
896 TENDON RUPTURE 75
897 TYPE I HYPERSENSITIVITY 75
898 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 74
899 ARTERIOSCLEROSIS 74
900 ARTERIOSCLEROSIS CORONARY ARTERY 74
901 CHOKING 74
902 DEVICE PHYSICAL PROPERTY ISSUE 74
903 ESSENTIAL HYPERTENSION 74
904 MELAENA 74
905 SCAB 74
906 THINKING ABNORMAL 74
907 WALKING AID USER 74
908 WOUND DEHISCENCE 74
909 CEREBRAL INFARCTION 73
910 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 73
911 DELUSION 73
912 HEPATOMEGALY 73
913 LACERATION 73
914 NEOPLASM 73
915 POISONING 73
916 SKIN REACTION 73
917 AORTIC STENOSIS 72
918 CANCER PAIN 72
919 COMPRESSION FRACTURE 72
920 DERMATITIS ATOPIC 72
921 DEVICE WIRELESS COMMUNICATION ISSUE 72
922 FLUID OVERLOAD 72
923 HORDEOLUM 72
924 HYPERTENSIVE CRISIS 72
925 HYPERTONIA 72
926 MYOSITIS 72
927 PRURITUS GENERALISED 72
928 RENAL FAILURE CHRONIC 72
929 RENAL PAIN 72
930 SUBARACHNOID HAEMORRHAGE 72
931 VENTRICULAR HYPOKINESIA 72
932 CARDIOVASCULAR DISORDER 71
933 CHOLECYSTECTOMY 71
934 DRUG ERUPTION 71
935 EYE INFLAMMATION 71
936 FULL BLOOD COUNT ABNORMAL 71
937 CARDIAC MURMUR 70
938 DELAYED RECOVERY FROM ANAESTHESIA 70
939 IMMUNE SYSTEM DISORDER 70
940 IMPAIRED DRIVING ABILITY 70
941 MULTIPLE FRACTURES 70
942 PELVIC FRACTURE 70
943 POST-TRAUMATIC STRESS DISORDER 70
944 RASH GENERALISED 70
945 VENTRICULAR ARRHYTHMIA 70
946 ABSCESS LIMB 69
947 ACUTE PULMONARY OEDEMA 69
948 ANALGESIC THERAPY 69
949 BREATH SOUNDS ABNORMAL 69
950 THIRST 69
951 BENIGN PROSTATIC HYPERPLASIA 68
952 CHOLECYSTITIS 68
953 COORDINATION ABNORMAL 68
954 DEAFNESS NEUROSENSORY 68
955 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 68
956 HICCUPS 68
957 INTERVERTEBRAL DISC DISORDER 68
958 TARDIVE DYSKINESIA 68
959 VASOPLEGIA SYNDROME 68
960 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 67
961 ATRIOVENTRICULAR BLOCK 67
962 GINGIVAL BLEEDING 67
963 JAUNDICE 67
964 PROCEDURAL NAUSEA 67
965 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 67
966 RESPIRATORY TRACT INFECTION VIRAL 67
967 SARS-COV-2 TEST POSITIVE 67
968 SLEEP DISORDER THERAPY 67
969 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 67
970 AUTONOMIC NERVOUS SYSTEM IMBALANCE 66
971 COMPLEX REGIONAL PAIN SYNDROME 66
972 DRUG THERAPY 66
973 INJECTION SITE EXTRAVASATION 66
974 MAJOR DEPRESSION 66
975 ORAL DISCOMFORT 66
976 OROPHARYNGEAL DISCOMFORT 66
977 RETINAL HAEMORRHAGE 66
978 SKIN HAEMORRHAGE 66
979 VARICOSE VEIN 66
980 EYE MOVEMENT DISORDER 65
981 HEPATITIS 65
982 HYPERTHYROIDISM 65
983 IMPLANT SITE EXTRAVASATION 65
984 INJECTION SITE RASH 65
985 METASTASES TO CENTRAL NERVOUS SYSTEM 65
986 OPHTHALMOPLEGIA 65
987 PYELONEPHRITIS 65
988 TOOTH EXTRACTION 65
989 UNINTENTIONAL MEDICAL DEVICE REMOVAL 65
990 CENTRAL NERVOUS SYSTEM LESION 64
991 EAR DISCOMFORT 64
992 EXTRASYSTOLES 64
993 FAILURE TO THRIVE 64
994 INCREASED APPETITE 64
995 NOCTURIA 64
996 PRODUCT LEAKAGE 64
997 BLINDNESS TRANSIENT 63
998 ERYTHEMA MULTIFORME 63
999 FRACTURE 63